Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|February 14, 2022
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic reviewMartin Vu, Koen Degeling, Ella R Thompson, et al.
Pharmacoeconomics|April 23, 2020
Health Economic Models for Metastatic Colorectal Cancer: A Methodological ReviewKoen Degeling, Martin Vu, Hendrik Koffijberg, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 20, 2020
Evaluating the resource implications of different service delivery models for offering additional genomic findingsMartin Vu, Koen Degeling, Melissa Martyn, et al.
Frontiers in Pharmacology|December 11, 2023
Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomesKarolina Zebrowska, Rosa C Banuelos, Evelyn J Rizzo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate CancerKoen Degeling, Niall M Corcoran, Amanda Pereira-Salgado, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate CancerKoen Degeling, Stefano Schivo, Niven Mehra, et al.
Pageof 4